ArticleFrontiers in immunology2022

What Is Long-Term Survival and Which First-Line Immunotherapy Brings Long-Term Survival for Advanced Wild-Type Non-Small Cell Lung Cancer: A Network Meta-Analysis Based on Integrated Analysis.

Xue Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.